Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

America has become a two-vaccine nation, but plenty of other companies are continuing to work on new vaccines that could increase supply and accelerate the country's goal of herd immunity.

Axios Re:Cap digs into the vaccine pipeline with Derek Lowe, a medicinal chemist and biotech blogger.

Go deeper

15 hours ago - Health

Bill and Melinda Gates warn of "immunity inequality"

Bill and Melinda Gates at a Goalkeepers event in 2018. Photo: Ludovic Marin/AFP via Getty Images

Bill and Melinda Gates warned in their annual letter Wednesday that the lasting legacy of the coronavirus pandemic could be "immunity inequality" — a wide and deadly gap between wealthy people, with easy access to coronavirus vaccines, and everyone else.

Why it matters: As long as there are large swaths of the world that can't get vaccinated, they warned, it will be impossible to get the pandemic under control.

Erica Pandey, author of @Work
14 hours ago - Economy & Business

Telework's tax mess

Illustration: Annelise Capossela/Axios

As teleworkers flit from city to city, they're creating a huge tax mess.

Why it matters: Our tax laws aren't built for telecommuting, and this new way of working could have dire implications for city and state budgets.

12 hours ago - Sports

Europe's 20 richest soccer clubs report 12% revenue hit due to coronavirus

Data: Deloitte; Table: Andrew Witherspoon/Axios

Europe's 20 most lucrative soccer clubs earned $9.97 billion in 2019-20, down from $11.31 billion the previous year, per Deloitte's 24th annual Football Money League report.

The state of play: That 12% drop was driven mostly by broadcast revenue deferrals, comprising a $1.14 billion decrease year-over-year. Matchday revenue also fell drastically, down $312.6 million.